$598.9 M

ENTL Mkt cap, 26-Feb-2018

$22.1 M

Entellus Medical Revenue Q2, 2017
Entellus Medical Gross profit (Q2, 2017)16.3 M
Entellus Medical Gross profit margin (Q2, 2017), %73.6%
Entellus Medical Net income (Q2, 2017)-8 M
Entellus Medical EBIT (Q2, 2017)-7.6 M
Entellus Medical Cash, 30-Jun-201762.9 M
Entellus Medical EV545.2 M

Entellus Medical Revenue

Entellus Medical revenue was $75.18 m in FY, 2016 which is a 22.1% year over year increase from the previous period.

Embed Graph

Entellus Medical Income Statement

Annual

USDFY, 2015FY, 2016

Revenue

61.6 m75.2 m

Revenue growth, %

22%

Cost of goods sold

14.1 m18.7 m

Gross profit

47.5 m56.5 m

Gross profit Margin, %

77%75%

R&D expense

5.4 m7.8 m

General and administrative expense

13 m18.6 m

Operating expense total

18.4 m26.4 m

EBIT

(15.9 m)(26.7 m)

EBIT margin, %

(26%)(36%)

Interest expense

2.6 m2.2 m

Interest income

171 k278 k

Income tax expense

(6 k)

Net Income

(18.3 m)(28.7 m)

Quarterly

USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

15.2 m14.8 m16.9 m18.7 m17.9 m19.1 m22.1 m

Cost of goods sold

3.3 m3.4 m4 m4.5 m4.6 m4.9 m5.8 m

Gross profit

11.8 m11.4 m12.9 m14.3 m13.2 m14.2 m16.3 m

Gross profit Margin, %

78%77%76%76%74%74%74%

R&D expense

1.3 m1.4 m1.9 m1.9 m2 m2.1 m2.1 m

General and administrative expense

3.1 m3.2 m3.9 m3.8 m4.8 m4.7 m5.8 m

Operating expense total

14.2 m16.9 m19.3 m18.8 m22.2 m22 m23.9 m

EBIT

(2.4 m)(5.6 m)(6.4 m)(4.5 m)(9 m)(7.8 m)(7.6 m)

EBIT margin, %

(15%)(38%)(38%)(24%)(50%)(41%)(35%)

Interest expense

562 k561 k562 k562 k562 k565 k446 k

Interest income

50 k47 k70 k83 k75 k62 k107 k

Income tax expense

34 k(3 k)(3 k)

Net Income

(2.9 m)(6.1 m)(6.9 m)(5 m)(9.5 m)(8.3 m)(8 m)

Entellus Medical Balance Sheet

Annual

USDFY, 2015FY, 2016

Cash

28.5 m21.4 m

Accounts Receivable

10.4 m

Inventories

3.9 m7.2 m

Current Assets

83 m54.9 m

PP&E

4.1 m6.5 m

Goodwill

477 k

Total Assets

87.4 m72.1 m

Accounts Payable

2.2 m2.8 m

Short-term debt

9.1 m

Current Liabilities

9.2 m24.9 m

Total Debt

9.1 m

Total Liabilities

36.6 m

Additional Paid-in Capital

179.7 m186.4 m

Retained Earnings

(122.1 m)(150.8 m)

Total Equity

57.6 m35.4 m

Debt to Equity Ratio

0.3 x

Debt to Assets Ratio

0.1 x

Financial Leverage

1.5 x2 x

Quarterly

USDQ2, 2015Q3, 2015Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

7.5 m8.7 m8 m15.2 m65.2 m62.9 m

Accounts Receivable

9.3 m10.2 m

Inventories

2.4 m3.3 m4.7 m5.9 m7.3 m7.7 m

Current Assets

92.8 m89.1 m64.6 m58.3 m91.2 m88.7 m

PP&E

2.8 m3.7 m5.2 m6.5 m6.6 m6.7 m

Goodwill

4.2 m4.3 m477 k477 k

Total Assets

95.8 m92.9 m80.5 m75.7 m108.2 m105.6 m

Accounts Payable

2.3 m3.4 m3.1 m4 m2.6 m3 m

Short-term debt

2.5 m4.1 m4 m6.6 m9.1 m9.1 m

Current Liabilities

11.1 m15 m15.4 m21 m19.9 m22.9 m

Total Debt

2.5 m4.1 m4 m6.6 m9.1 m9.1 m

Total Liabilities

29 m31.4 m32 m35.2 m33.2 m36.2 m

Additional Paid-in Capital

177.8 m178.6 m182.5 m184.1 m234.2 m236.6 m

Retained Earnings

(111 m)(117 m)(134 m)(143.5 m)(159.1 m)(167.2 m)

Total Equity

66.9 m61.6 m48.5 m40.5 m74.9 m69.3 m

Financial Leverage

1.4 x1.5 x1.7 x1.9 x1.4 x1.5 x

Entellus Medical Cash Flow

Annual

USDFY, 2015FY, 2016

Net Income

(18.3 m)(28.7 m)

Depreciation and Amortization

1 m2.1 m

Inventories

(1.5 m)(3.3 m)

Accounts Payable

(206 k)596 k

Cash From Operating Activities

(14.2 m)(20.1 m)

Purchases of PP&E

(3.4 m)

Cash From Investing Activities

(42.1 m)12.3 m

Cash From Financing Activities

81.3 m782 k

Interest Paid

1.9 m1.9 m

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(2.9 m)(6.1 m)(6.9 m)(5 m)(9.5 m)(8.3 m)

Accounts Receivable

8.4 m9.3 m10.2 m

Inventories

2.6 m2.4 m3.3 m4.7 m5.9 m7.3 m

Accounts Payable

2 m2.3 m3.4 m3.1 m4 m2.6 m

Entellus Medical Ratios

USDY, 2017

EV/EBIT

-71.4 x

Financial Leverage

1.5 x
Report incorrect company information